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Abstract
Primary ciliary dyskinesia (PCD) is a rare (1/20,000), multisystem disease with a complex phenotype caused by the impaired
motility of cilia/flagella, usually related to ultrastructural defects of these organelles. Mutations in genes encoding radial
spoke head (RSPH) proteins, elements of the ciliary ultrastructure, have been recently described. However, the relative
involvement of RSPH genes in PCD pathogenesis remained unknown, due to a small number of PCD families examined for
mutations in these genes. The purpose of this study was to estimate the involvement of RSPH4A and RSPH9 in PCD
pathogenesis among East Europeans (West Slavs), and to shed more light on ultrastructural ciliary defects caused by
mutations in these genes. The coding sequences of RSPH4A and RSPH9 were screened in PCD patients from 184 families,
using single strand conformational polymorphism analysis and sequencing. Two previously described (Q109X; R490X) and
two new RSPH4A mutations (W356X; IVS3_2–5del), in/around exons 1 and 3, were identified; no mutations were found in
RSPH9. We estimate that mutations in RSPH4A, but not in RSPH9, are responsible for 2–3% of cases in the East European PCD
population (4% in PCD families without situs inversus; 11% in families preselected for microtubular defects). Analysis of the
SNP-haplotype background provided insight into the ancestry of repetitively found mutations (Q109X; R490X; IVS3_2–5del),
but further studies involving other PCD cohorts are required to elucidate whether these mutations are specific for Slavic
people or spread among other European populations. Ultrastructural defects associated with the mutations were analyzed
in the transmission electron microscope images; almost half of the ciliary cross-sections examined in patients with RSPH4A
mutations had the microtubule transposition phenotype (9+0 and 8+1 pattern). While microtubule transposition was a
prevalent ultrastructural defect in cilia from patients with RSPH4A mutations, similar defects were also observed in PCD
patients with mutations in other genes.
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Introduction
Primary ciliary dyskinesia (PCD; MIM #242650) is a rare,
multisystem disease with the prevalence of 1/20,000 [1].
Characterized by recurrent respiratory infections, bronchiectasis,
male infertility, and randomization of body organ symmetry, PCD
is primarily caused by the impaired motility of respiratory cilia,
spermatozoid flagella and primary cilia of the embryonic node
[2,3]. Genetically heterogeneous, PCD is usually inherited as an
autosomal recessive trait [4–7]. To date, PCD-causing mutations
have been found in twelve genes, encoding proteins involved in the
ciliary ultrastructure (DNAH11, DNAI2, DNAL1, TXNDC3,
RSPH9, RSPH4A, CCDC39, CCDC40) or assembly (KTU, LRRC50)
[8–26]; mutations in RPGR and OFD1 have been reported in rare
syndromic forms of PCD [27–30].
In most PCD cases, dysfunction of cilia or flagella is caused by
defects of their ultrastructure. The main part of a cilium, the
axoneme, is built on a scaffold of microtubules (MT) projecting
from the cell surface. In motile cilia and flagella, nine peripheral
MT doublets surround the central pair of MTs (9+2); primary cilia
lack the central pair (9+0) [1]. Peripheral doublets in 9+2 cilia are
associated with a variety of structures, distributed periodically
along the MT length: outer and inner dynein arms producing the
force needed for ciliary motility, nexin links connecting the
neighboring doublets, and radial spokes providing contact between
peripheral doublets and the central pair. Transmission electron
microscopy (TEM) reveals aberrations of the axonemal ultrastruc-
ture in over 80% of PCD patients [31]. The most commonly
reported defects involve absence or shortening of dynein arms.
Accordingly, mutations in DNAI1 and DNAH5 genes encoding
outer dynein arm proteins have been collectively estimated to
account for 30–40% of PCD cases [23,32]. Anomalies of MT
arrangement comprise another class of frequently observed defects
[33,34]. Mutations in CCDC39 and CCDC40 genes, encoding
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have been reported in a considerable number of PCD patients
with defects in MT arrangement [24,26]. RSPH4A and RSPH9,
both encoding radial spoke head proteins, are other genes reported
to be mutated in PCD patients with MT defects [19]. However,
the fact that only a small number of preselected families have been
examined so far leaves the unsolved question of the overall
involvement of RSPH genes in PCD pathogenesis. Also, data on
ultrastructural cilia defects in patients with RSPH defects remain
scarce.
Here, we report the results of mutation screening in RSPH4A
and RSPH9, performed in a large group of Polish PCD patients
recruited without any preselection. Our data indicate that
mutations in RSPH4A, but not in RSPH9, can be considered a
relatively frequent cause of PCD in East-European populations. In
addition, new TEM data enrich the existing knowledge of a
genotype-phenotype correlation in patients with RSPH4A muta-
tions.
Results
RSPH4A gene
Gene sequence analysis. Fifteen SSCP variants were found
upon screening of RSPH4A in PCD patients. Nine common SNPs
(see next paragraph), previously reported in SNP database, were
found also in healthy controls. Analysis of the remaining six
variants’ occurrence is presented in Fig. 1-A, 1-B and Table 1.
A homozygous c.325C.T transition, introducing a premature
stop codon Q109X in exon 1, was found in one family (#212) with
two affected siblings. There was reported consanguinity in the
family; two unaffected sisters did not carry the mutation. A
c.1468C.T transition, resulting in R490X in exon 3, was found in
a heterozygous state in two families (#237 and #178). In a solitary
proband from family #237, it was accompanied by c.1068G.A,
resulting in W356X in exon 3. In two affected sisters from family
#178, the R490X was accompanied by a deletion of 4 nucleotides
at the intronic positions IVS3+(2–5); the latter mutation was also
carried by two unaffected brothers. The IVS3+(2–5)del was also
found in a homozygous state in two affected sisters from yet
another family (#269), where no information on parental
consanguinity had been provided. Although no RNA was
available to examine the effect of IVS3+(2–5)del on splicing, we
assumed that this variant represented a splice-site mutation, based
on a number of observations. First, IVS3+(2–5)del changed the
canonical splice site and the first two positions of the deletion were
conserved in the interspecies comparison with RSPH4A ortholo-
gues from 13 Eutherian mammals (Table 2). Second, the deletion
was absent from ,200 unrelated healthy control chromosomes.
Finally, in silico examination of the effect of IVS3+(2–5)del on the
predicted splice sites (Table 3) confirmed that this change
abolished the existing donor site, resulting in a frameshift and a
premature stop codon.
The remaining two sequence changes identified in the examined
PCD patients were: IVS5 24A.G and 39UTR+(195–205)del. No
SNPs were reported at the respective gene positions in the human
SNP database (build 134). The intronic A.G transition was found
in a heterozygous state in three non-related PCD patients. It was
absent from ,400 healthy control chromosomes and, in the
interspecies comparison with RSPH4A orthologues from 13
mammalian species (Table 2), an A at the IVS5 position 24w a s
conserved in all these species except S. scrofa, for which this segment
was not present in the alignment. However, in silico analysis did not
predict any change in the existing splice sites (data not shown), and
no complementing mutation was identified, in spite of sequencing
the whole RSPH4A coding sequence in the three patients carrying
the transition. Two patients carrying this allele had situs inversus,a n d
the third patient had no defect of MT organization in TEM; thus,
theirphenotypeswerediscordantwith thatconsidered characteristic
for radial spoke defects (see the next paragraph and Discussion).
Based on the above observations, we assumed that IVS5-4A.G did
not represent a causative PCD mutation. The deletion of 11 bp in
the 39UTR+(195–205) was found on a single PCD chromosome
(with no complementing mutation identified in the patient), and in 5
out of ,440 examined healthy control chromosomes. We analyzed
the possibility that this deletion affected bindingsite of miRNAs, but
no evidence was found of the predicted miRNA in the region of the
deletion (data not shown). This segment was also not strongly
conserved in the interspecies comparison (Table 2). Based on the
above findings, 39UTR+(195–205)del was considered to represent a
neutral polymorphism.
In summary, three sequence changes that resulted in a STOP
mutation, and one that affected the conserved donor splice site
position, were directly assumed to represent causative PCD
mutations. The positioning of body organs in all the patients
carrying these mutations was normal, i.e. no situs inversus was
observed (Table 1).
SNP haplotype background of RSPH4A mutations. To
elucidate, whether a founder effect was responsible for the
repeated occurrence of Q109X, R490X and IVS3+(2–5)del
mutations, nine-position SNP haplotypes in eight mutation-
carrying chromosomes were compared with haplotypes in other
PCD and non-PCD chromosomes (Table 4). As expected, two
alleles carrying Q109X (c.325C.T) in homozygous siblings #337
and #340 had an identical haplotype background (C-G-G-G-C-g-
A-a-t). Another haplotype (C-A-G-A-C-g-A-a-c) was found in
three unrelated chromosomes carrying IVS3+(2–5)del, indicating
that they shared a common ancestor. The possibility of recurrent
mutation events on these three chromosomes was relatively low,
since the background haplotype was rare among non-affected
chromosomes (,2%) and relatively recent (separated by three
SNP positions from the ancestral haplotype). R490X was found on
two independent chromosomes, each on a different background
(C-G-G-G-T-g-A-a-t and C-G-G-G-C-g-A-a-c). This could be
explained by either a recombination of the mutation-carrying
haplotype or by recurrent mutation events (see Discussion).
Effect of RSPH4A mutations on the ciliary
ultrastructure. TEM data were available for three of the
four families with RSPH4A mutations. In all these cases, analyses
revealed defects of MT organization, albeit a significant
proportion of ciliary cross-sections with a normal 9+2 pattern
were also present (Fig. 2-A; Table 5). An absence of the central
pair (9+0) was the most frequently found MT defect. In many cilia,
the lack of the central pair was associated with various stages of a
displacement of one of peripheral doublets (8+1). Jointly, 9+0 and
8+1 patterns represented 38–54% of all cross-sections examined.
Other MT abnormalities, including 9+1, 9+4, 9+3, 8+0, 8+2, 7+1
were rare (none was found in more than 6% of the cross-sections
examined). Cilia with a 9+1 pattern were seen only in patient
#181 (2%), while cilia with supranumeral central MTs (9+4 and
9+3) were observed more frequently in the siblings #337 and
#340 than in #181 (8% vs 3%). The differences in the proportion
of 9+4 and 9+1 cilia could be related to the differential effect
of underlying mutations (#337/#340 were Q109X/Q109X
homozygotes and #181 was a compound heterozygote W356X/
R490X); the increased proportion of cilia with rare, non-specific
patterns in #337 and #340 most probably represented acquired
abnormalities. Ciliary disorientation, with a discordant alignment
of the central pair in neighboring cilia, was observed in all patients,
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PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e33667Figure 1. PCD families with new sequence changes identified in RSPH4A and RSPH9 genes. A Causative mutations in RSPH4A. Segregation
of the mutated alleles is consistent with the recessive mode of inheritance. No situs inversus was observed in any of the affected members; B New
SNPs in RSPH4A; C New SNPs in RSPH9. Upper panels – pedigrees of the families; lower panels – sequencing chromatograms.
doi:10.1371/journal.pone.0033667.g001
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dyneinarmswere notdistinguishable,evenincross sections withthe
normal MT pattern; this could be a part of the RSPH4A defect-
related picture, but could also reflect an inadequate quality of
specimens. Outer dynein arms appeared normal, both in 9+2
axonemes and in those with defective MT arrangements (Fig. 2-B).
The latter observation confirmed that the frequently observed 9+0
pattern reflected the loss of the central pair rather than a fortuitous
localization of the cross-section plane at the transition zone of the
axoneme. In the specimen from patient #181, where TEM pictures
of 14 different fields were available for the analysis, two classes of
cross-sections were observed – proximal (as indicated by the large
number of microvilli), and more distal, without microvilli (Fig. 2-A).
The proportion of 9+0 patterns was much higher among the
proximal cross sections, while in the distal part of the axoneme, 9+0
was largely replaced by 8+1, with the transposed peripheral
doublets positioned either asymmetrically or in the center of the
axoneme (Table 5). Longitudinal sections of a few cilia from patient
#337 confirmed the presence of a classical ciliary transposition
defect, but also showed that some of the cilia had the central pair
retained throughout the whole length of an axoneme (Fig. 2-C).
RSPH9 gene
SSCP screening of the entire coding region of RSPH9, performed
in PCD patients, revealed four sequence variants. One, in exon 5,
was a known SNP (rs16896629). Three other changes (Fig. 1-C)
have never been described before. A heterozygous 214G.C
Table 1. Details of patients’ phenotypes and sequence changes in RSPH4A.
Allele 1 Allele 2
Family Patient s.i. nNO Defects Location DNA Effect Location DNA Effect
212 337 no n.a. MT exon1 325C.T Q109X exon1 325C.T Q109X
212 340 no n.a. MT exon1 325C.T Q109X exon1 325C.T Q109X
237 536 no 75.0 n.a. exon1 1068G.A V356X exon3 1468C.T R490X
178 181 no 44.2 MT intron3 IVS3+2–5 (TAGG)del DSS intron3 1468C.T R490X
269 604 no 125.0 MT intron3 IVS3+2–5 (TAGG)del DSS intron3 IVS3+2–5
(TAGG)del
DSS
269 605 no n.a. MT intron3 IVS3+2–5 (TAGG)del DSS intron3 IVS3+2–5
(TAGG)del
DSS
262 586 yes n.a. n.a. intron5 IVS5 24A.G? - --
162* 131 yes n.a. n.a. intron 5 IVS5 24A.G? - --
111 432 no n.a. n.a. intron 5 IVS5 24A.G? - --
210 318 yes n.a. n.a. 39UTR 39UTR+195–
205(11 bp)del
?- --
Causative mutations are shown in bold; the remaining changes (in intron 5 and in 39UTR) are newly described SNPs. s.i. – situs inversus; nNO – nasal NO (parts per
billion), average from 3–4 measurements (ozone-chemiluminescence NO analyzer, GE Analytical Instruments); MT – microtubules; n.a. – not analyzed; ? – effect
unknown, presumably neutral mutation; DSS – mutation in a conserved donor splice site; an asterisk indicates a family of Slovak origin.
doi:10.1371/journal.pone.0033667.t001
Table 2. Evolutionary conservation of the genomic sequence surrounding newly found sequence changes in the RSPH4A gene.
Gene region Intron3 (+2–5del) Intron5 (24A.G) 39UTR (+195del11 bp)
Homo sapiens TCAGGTAGGAGCTTT TACTT-ATAGAAA AAGATACTCACAGGATTTTCC
Pan troglodytes ............... .....-....... .....................
Gorilla gorilla --------------- .....-....... ..........T..........
Pongo abelii ............... .....-....... ...........G.........
Macaca mulatta ............... .....-.C..... ..........TG.........
Callithrix jacchus .......A.GA.... .....-....... .....G....GG.........
Equus caballus .........G..... A..C.-.C..... ....T.....ACA........
Sus scrofa .........G..... ------------ ---------------------
Bos taurus .........G.T... .....-.C..... .....G....ACA......T.
Canis lupus famil. .........G.T... A....T....... G....G..TGAT..G......
Mus musculus .......T.G.AG.A CC...-....G.. ---------------------
Rattus norvegicus .......ATG..GCC C....-.C..G.. ---------------------
Oryctolagus cunic. .......TAG..... .T...-....G.. .....................
Mutated sequences are underlined. A point denotes identity, dash – deletion; fragments of the sequences of exon 3 and 6 in RSPH4A are shown in bold.
doi:10.1371/journal.pone.0033667.t002
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no other accompanying mutation identified in the entire coding
region. This variant was not found among 186 healthy control
chromosomes. Two heterozygous transitions, 52A.G and 73G.A,
were found in the 39UTR, each in one of two unrelated patients; no
accompanying mutations were identified. Both transitions were
absent from ,210 chromosomes from unrelated Polish non-PCD
individuals. Interrogation of the human SNP database (build 134)
did not indicate SNPs at the respective gene positions.
The biological meaning of the three newly found mutations is
difficult to establish without analyzing cDNA, which was not
available. Comparison with the RSPH9 orthologues from 13
Eutherian mammals indicated 100% conservation of A at position
52 of the 39UTR; 73G in the 39UTR and 214G in the 59UTR
were less conserved (Table 6). The possibility that the 39UTR
mutations affected binding site of miRNAs was examined using
the MIRANDA online tool. The 52A was found to be a part of the
sequence recognized by several miRNAs (Fig. 3). The A.G
Table 3. In silico prediction of the effect of IVS3+2–5del in the RSPH4A gene.
RSPH4A sequence Splice site
Putative splice site position within the gene
sequence Confidence score
Comparison with the default
splice site; effect on splicing
Normal Donor TCTCTCTCAGˆgtaggagctt 0.63 Default
Normal Acceptor gtttccccagˆGCAGAAAACG 0.22 Default
Mutated Donor GAGGCAGAAGˆGTGGGCGAAA 0.55 Alternative in exon; frameshift
Mutated Donor aatctatcagˆgtaattaggc 0.41 In intron; frameshift
Mutated Donor attgtgccagˆgtgtgtgtgt 0.41 In intron; frameshift
Mutated Donor cttggaaaatˆgtatgtagaa 0.32 In intron; frameshift
Mutated Acceptor gtttccccagˆ
GCAGAAAACG 0.22 No change
Default splice sites in IVS3 result in the proper protein sequence (donor in phase 2, acceptor in phase 0). All alternative donor sites predicted for the sequence with
IVS3+2–5del mutation (located either within exon 3 or within intron 3, all in phase 1) result in a frameshift and a premature stop codon; acceptor site remains
unchanged. Intronic sequences in the RSPH4A sequence are indicated by lowercase letters. The two most conserved positions of a consensus donor and acceptor splice
site are underlined.
doi:10.1371/journal.pone.0033667.t003
Table 4. SNP haplotypes in the RSPH4A gene.
SNPs/mutations S1 M1 S2 M2 M3 S3 M4 S4 S5 S6 S7 S8 S9 S10 S11
Location e1 e1 e2 e3 e3 e3 i3 e4 e4 i4 e5 i5 39 39 39
Ancestral allele CC GG C GN 1GCGAAN 2A T
Haplotypes PCD Non-PCD
Neutral 1 A 54 42
Neutral 2 31
Mutated 1 T 2* -
Neutral 3 CC 7 8
Neutral 4 G 24 27
Neutral 5 G A 5 7
Mutated 2 G A 1-
Neutral 6 T8 7 6 9
Neutral 7 TC 3 0
Mutated 3 T T1 -
Mutated 3r T C1 -
Neutral 8 AC 4 9 4 1
Neutral 9 AD 2 C 2 4
Neutral 10 A A C 4 3
Mutated 4 A D1A C 3 -
SNPs: S1: rs13213314; S2: rs41289942; S3: re117169123; S4: rs6927567; S5: rs784133; S6: 41290844; S7: rs9488991; S8: new; S9: new; S10: rs9488993; S11: rs6925922.
Mutations: M1: Q109X (rs118204042); M2: W356X (new); M3: R490X (rs118204043); M4: IVS3+(2–5)del (new). Only the derived (non-ancestral) alleles are indicated in the
haplotype variants; causative alleles in the ‘‘mutated’’ haplotypes are in bold. Counts of each haplotype in the examined PCD and non-PCD chromosomes are indicated
in two rightmost columns; haplotype frequency distribution did not significantly differ between the affected and non-affected chromosomes (Fisher exact test, not
shown). The single haplotype 3r, carrying one of two R490X alleles, contains a putative recombination between the mutation-carrying haplotype 3 and the frequent
neutral haplotype 8. An asterisk indicates two mutation-carrying chromosomes found in the single consanguineous family. N1=TAGG in IVS3_2–5; N2=GATACTCACAG
in 39UTR; D1=TAGG deletion in intron 3; D2=GATACTCACAG deletion in 39UTR; e – exon; i – intron; 39 –3 9UTR.
doi:10.1371/journal.pone.0033667.t004
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score for miR-127-5p (A:C.G:C), at the same time retaining the
complementarity of four other miRs (A:U.G:U in 27b*, 100*,
590-5p and 2). Verification of the possibility that 52A.G
transition affected the level of RSPH9 expression would require
extensive experimental analyses; this issue was not pursued further,
given that a heterozygous 52A.G was found in only one patient
with no other changes in RSPH9. In summary, we conservatively
assumed that none of the newly identified alleles in RSPH9
represented causative PCD mutations.
Discussion
Our study represents the first large-scale screening of radial
spoke head protein genes performed in PCD families, in our case,
ones of East-European (Slavic) origin. The earlier report on
mutations in RSPH4A and RSPH9 [19] has been based on a much
smaller study group of seven PCD families preselected for the
presence of MT defects, and included only a single European
family.
We did not detect any causative RSPH9 mutation among the
examined PCD patients. The absence of c.801-803delGAA
(K268del), reported earlier in Bedouins from United Arab Emirates
and Israel [19], confirms the population-specific character of this
mutation. We postulate that the involvement of RSPH9 in PCD
pathogenesis among Europeans, or at least in Slavic populations, is
negligible.
On the contrary, our data proved that mutations in RSPH4A are
responsible for a significant proportion of PCD cases among the
Slavic people. Although c.504C.T (Q154X), reported earlier in
four Pakistani families [19], was not found (suggesting its Pakistani-
specific origin), four other disease-causing RSPH4A mutations were
identified in four Polish families. Importantly for diagnostic
purposes, all causative mutations detected up to date clustered in
or around exons 1 and 3.
Two of these mutations (Q109X and R490X), previously
reported in a compound heterozygote from a single North UK
family, were detected in two Polish chromosomes each. Q109X
was found in homozygous siblings from a single family; both
Q109X alleles had the same SNP haplotype background,
consistent with the declared parental consanguinity. Lack of
SNP haplotype data in the previous report [19] prevented us from
determining whether Q109X mutations found in Polish and UK
families were identical by descent. For the same reason, we could
not determine a shared or independent ancestry of Polish and UK
chromosomes with R490X. In the Polish cohort, R490X was
found on two different backgrounds. Since the mutation results
from the c.1468C.T transition at a fast-mutating CpG dinucle-
otide [39], the possibility of its redundant origin is high. On the
other hand, the C-G-G-G-C-g-A-a-c background was not found in
any of the examined non-PCD chromosomes, but could be easily
explained by a recombination of R490X-carrying C-G-G-G-T-g-
A-a-t with another frequent haplotype (Table 4), suggesting that
R490X on two different backgrounds could in fact be identical by
descent. Of the two newly discovered mutations, W356X was
found on a single chromosome, while IVS3_2–5del was repeated
on three independent chromosomes. All chromosomes carrying
IVS3_2–5del shared the same haplotype (C-A-G-A-C-g-A-a-c)
that was rare among non-affected chromosomes and separated by
three SNP positions from the ancestral haplotype, which indicates
that it is evolutionary young [40]. IVS_2–5del appears therefore to
be a relatively recent mutation; further studies involving other
PCD cohorts are required to elucidate whether this mutation is
restricted to Polish population or spread among other European
groups.
TEM analysis of ciliary cross-sections from bronchial epithelium
of patients with RSPH4A mutations revealed that a ciliary MT
transposition, with the loss of the central pair (9+0 pattern),
accompanied by a translocation of one of the peripheral doublets
(8+1 pattern), was the predominant defect of the ciliary
ultrastructure. Frequency of cilia with other abnormalities (each
representing less than 4% of the cross sections) was not different
from that expected in specimens from healthy individuals [41].
The previously reported estimates of the overall proportion of cilia
with central MT defects have ranged from ,14% in patients with
transposition defects [33] to 12.5–17% in patients with central pair
agenesis [42]. In our study, the 9+0 pattern was seen in 15–47%,
and 8+1 in 9–30% of the examined ciliary cross-sections. The
proportion of 9+0 and 8+1 cilia depended on the plane of a cross-
section (9+0 prevailed in the proximal, and 8+1 in the distal
sections), confirming the previous observation that the loss of the
central pair in a major proportion of cilia represents a proximal
picture of a ciliary transposition defect [43].
Mutations affecting the RSPH4A protein have been described
by Castleman et al. [19] as being associated with a classic
transposition defect indicative of ‘‘a complete central pair loss’’.
This description is incorrect, since neither a classic ciliary
Figure 2. Transmission electron microscope analysis of the
bronchial epithelium samples from PCD patients with RSPH4A
mutations. A Ciliary cross sections – magnification 30,000 (patient
#181). Left panel – a typical picture of proximal ciliary cross sections
(cilia are accompanied by numerous microvilli); right panel – ciliary cross
sections taken at the distance from the cell membrane (no microvilli
present); B Examples of MT defects in patients #181, #337 and #340 (a
blown-up view). C Longitudinal sections of axonemes (patient #337);
left panel: magnification 16,000; right panel – a blown up view of a
single cilium. White, black and hashed arrows indicate 9+2, 9+0 and 8+1
MT arrangement, respectively.
doi:10.1371/journal.pone.0033667.g002
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center, nor even a central microtubular agenesis [42] are
associated with a ‘‘complete’’ loss of the central pair [33,42]. In
a transposition defect, the central pair in cilia has been reported to
extend only a short distance [44]. In our study, a significant
proportion of cross sections with a normal 9+2 pattern (35–37%)
was observed not only in the proximal but also in the distal region,
indicating that the lack of a functional RSPH4A protein and the
resulting defect of radial spoke heads affected MT arrangement
only in some of the axonemes. This could suggest that not only the
translocation of a peripheral doublet to the center of the axoneme
(8+1) [43], but also the lack of the central pair (9+0) could be
considered a secondary effect.
Similar to Castleman et al. [19], we found RSPH4A mutations
only in PCD patients without situs inversus. This is consistent with
the hypothesis that defects in radial spoke head proteins do not
affect functioning of 9+0 nodal cilia and thus do not impair
development of body organ symmetry.
Table 5. MT defects in ciliary cross-sections from patients with RSPH4A mutations.
Cross-section details Patient #181 Patient #337 Patient #604
Microvilli Numerous Absent Few Nd
Cross-section plane Proximal Distal Ambiguous Nd
Number of fields examined 7 7 4 1
9+2 (normal MT pattern) 62 (35%) 78 (47%) 37 (37%) 2
9+0 83 (47%) 28 (15%) 26 (27%) 5
8+1C 6 3 8 5 0
8+1E 7 1 2 6 0
8+1P 3 4 1 0
All 8+1 16 (9%) 54 (30%) 12 (12%) 0
9+16 6 0 0
9+44 2 6 0
9+32 3 1 0
7+11 2 0 0
8+21 2 2 2
8+01 1 1 0
Various 1 5 14 0
All other than 9+2, 9+0 and 8+1 16 (9%) 21 (8%) 24 (22%) 2
Total count of examined cilia 177 182 98 7
Letters C, E and P next to the 8+1 MT pattern denote position of a transposed doublet in the axoneme: central, eccentric and at the perimeter, respectively. Nd: cross-
section plane and the presence of microvilli not determined, due to the low number of ciliary cross-sections.
doi:10.1371/journal.pone.0033667.t005
Table 6. Evolutionary conservation of the genomic sequence surrounding newly found sequence changes in the RSPH9 gene.
Gene region 59UTR (220G.C) 39UTR (+52A.G and +73G.A)
Homo sapiens TGAGCGGAGCCGCT TTCTTAAGCTTCAGTGAACTTGGCCTGCCTGT
Pan troglodytes .............. ................................
Gorilla gorilla .............. ................................
Pongo abelii .....A........ ................................
Macaca mulatta .....A...A.... .........................C......
Callithrix jacchus .....A.......A ...........................GT...
Equus caballus -------------- .......AT.........T....T...TT---
Canis lupus famil. -------------- ...A...A.AG.T.....T...CT...TT...
Sus scrofa .......G.AG... ...A...AG...G.C.....G..T.C.TT---
Bos taurus .....A....T..C ...A...AG-..G.....TC...T.G.T....
Mus musculus G...GA..A.G... ...A...AG....ACT-GT.G.....TTT...
Rattus norvegicus G...G...A.G... ...A...AG....ACC-.T.G..T....T...
Oryctolagus cunic. .....T.......G ..TA...ATGGT....T....CC-..C.T...
Mutated sequences are underlined. A point denotes identity, dash – deletion.
doi:10.1371/journal.pone.0033667.t006
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indicates that this gene is involved in PCD pathogenesis in 2.2% of
Polish PCD families, or in ,4% considering only families without
situs inversus (Table 7). It is important to emphasize that these
estimations are based on the cohort recruited without any
preselection with respect to ultrastructural defects. The frequency
of RSPH4A mutations in Polish PCD population preselected for
defects of ultrastructure would be much higher. To assess the effect
of such preselection in the calculation of RSPH4A involvement, we
reexamined descriptions of diagnostic TEM data available for
Polish probands (data not shown). In most cases, an absence of
dynein arms (outer, outer/inner or inner) was reported in the
majority of cross sections, while MT arrangement defects were
observed only in a small proportion (less than 10%) of cilia. Since
heterogeneous MT defects have been demonstrated in acquired
(secondary) ciliary dyskinesia [45], and occasionally even in
healthy individuals [41], we did not consider such low frequency
MT defects to represent a primary effect of any specific mutation.
However, in 24 probands, MT defects were observed in 13–60%
of the scored cilia. Mutations in RSPH4A were identified in three
of these 24 patients, suggesting that mutations in this gene may be
involved in over 12% of PCD families with predominant MT
defects. The remaining 21 cases with prevalent MT defects could
have included patients with mutations in other genes, e.g. CCDC39
or CCDC40 recently demonstrated to display characteristic MT
arrangement defects [24,26]. Interestingly, two patients from this
subgroup had mutations in DNAI1 [23], and three had mutations
in DNAH5 (our unpublished data), both genes primarily associated
with defects in outer dynein arms. Earlier reports have indicated
that in patients with dynein arms defects, only ,5% of cilia display
MT defects [33,45]; our data show that mutations in dynein arms
proteins may be associated with much more prevalent MT defects.
They also indicate that, while predominant MT defects may be
considered indicative of dysfunctional RSPH4A, they are not
specific for mutations in this protein.
Materials and Methods
Ethics Statement
An informed consent was obtained from all the participating
individuals or their parents; the research protocol was approved by
the Ethics Committee of the Medical University in Poznan.
Patients
The study group comprised the previously described cohort of
157 PCD families, including 151 of Polish and 6 of Slovak origin
(Slovakians are very closely related to Poles), and additional 27
Polish families recruited [23]. In the combined cohort (213
affected), 85 families were classified as Kartagener syndrome, KS
(at least one affected member displayed situs inversus). The families
were recruited without a preselection for ultrastructural defects,
although TEM data were available for ,50% of the probands. At
least one of the three criteria listed below had to be fulfilled to
include a patient in the PCD cohort: i) typical clinical symptoms
(recurrent upper respiratory tract infections, recurrent pneumonia,
chronic bronchitis, bronchiectasis, sinusitis and otitis media, and
Figure 3. Localization of the sequences recognized by Homo sapiens micro RNAs (Hsa miRNAs) within the 39UTR of RSPH9 sequence.
The genomic sequence (last 15 bp of exon 6 and first 105 bp of 39UTR) shown in the left column is underlined with the dotted line, with the coding
sequence and UTR indicated by upper and lower case, respectively; positions +52A and +73G, mutated in some samples, are indicated (bold and
heavy underline). MiRNA sequences identified through in silico search are shown below, aligned with the genomic sequence, with the
complementary bases shown in uppercase. MirSVR scores (support vector regression algorithm for the prediction of the miRanda-predicted
microRNA target sites; [38]) are indicated next to each miRNA name; high scores are underlined. The A at position +52 in the 39UTR sequence is
complementary to U in four miRNAs; the A.G transition at +52 would increase complementarity between 39UTR and the miR-127-5p. No miRNAs
complementary to the sequence encompassing +73 in the 39UTR were found.
doi:10.1371/journal.pone.0033667.g003
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saccharine test) associated with situs inversus (85 families); (ii) typical
clinical manifestation without situs inversus, but with the presence of
a defect in the ciliary ultrastructure (41 families); (iii) typical clinical
symptoms without situs inversus, and the absence of ciliary motility
as seen in the light microscope (58 families). Cystic fibrosis was
excluded on the basis of a clinical picture and an absence of most
frequent CFTR mutations [35]. Parental consanguinity was
reported in one family; otherwise, consanguinity was neither
reported nor formally excluded. The control group consisted of
,100 non-PCD Polish individuals, and of parental chromosomes
that were not transmitted to affected offspring in PCD families.
Search for mutations was not executed in 28 families where two
mutated alleles have been previously identified in other PCD-
related genes [23; our unpublished data]. In RSPH4A, the search
was discontinued in 16 families, where the segregation of SNP
haplotype was inconsistent with that of the disease. However, all
184 PCD families were included in calculating the overall RSPH4A
involvement in PCD pathogenesis.
PCR amplification and SSCP/heteroduplex analysis
Genomic DNA was isolated from peripheral blood lymphocytes
using a standard salting-out extraction. Primer pairs were designed
to amplify all exons (six in both RSPH9 and RSPH4A) and splice
junctions, as well as the 59 and 39 untranslated (UTR) regions. The
lengthofeachampliconwas,300 bp;someexonswereanalyzedin
2–4 overlapping parts. PCR-amplified segments were denatured
and separated in native polyacrylamide gels [23]. Primer sequences,
PCR conditions and detailed SSCP conditions are available from
the authors upon request.
Sequence analysis
Nucleotide changes underlying the detected SSCP migration
variants were resolved by direct sequencing of PCR products [23].
The reference genomic sequences for RSPH4A (previously RSH3L)
were ENSG00000111834 (www.ensembl.org); exon boundaries were
of the 717 amino acid RSPH4A-02 transcript ENST00000229554.
The corresponding reference sequences for RSPH9 were
ENSG00000172426; exon boundaries were of the 306 amino acid
RSPH9-02 transcript ENST00000372163. The effect of mutations on
the predicted splice sites was examined in silico,u s i n gN e t G e n e 2o n l i n e
software (http://cbs.dtu.dk/services/NetGene2 [36,37]). The possible
effect of 59UTR mutations on miRNA-binding sites was examined
using MIRANDA online tool (http://www.microrna.org/ microrna
[38]). Segregation of RSPH4A haplotype composed of nine known
intragene SNPs was examined in 153 families; converting genotype
data into haplotypes was done as previously described [23].
Transmission electron microscopy (TEM)
Respiratory epithelial cells from bronchial biopsies were obtained
during routine diagnostic procedures. The cells were fixed in 2.5%
glutaraldehydein0.1 Msodiumcacodylate bufferat4uC,post-fixed
in 1% osmium tetroxide, dehydrated and embedded in a mixture of
propylene oxide and epoxy resin. Ultramicrotome sections were
stained with Reynold’s lead citrate. Observations wereperformed at
16–30,000-fold magnification (Philips CM10).
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